Company / Working Capital per Share
CRISPR Therapeutics AG Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$21.42
FY2025
5-year range
$21.42 / $31.08
FY2021-FY2025
Trend
-7.3%
vs FY2024
Sector context
#18 of 212
Health Care
What the data says
Among 212 Health Care companies, CRISPR Therapeutics AG is in the top 8% for working capital per share. Working Capital per Share has fluctuated over the past 10 years, ranging from $5.89 in FY2017 to $53.94 in FY2016.
Based on SEC 10-K filings.
21.42 in FY2025 with a 5-year CAGR of -4.3%. Top quartile in the Health Care sector.
Declined from $22.92 to $21.42 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -1.6%
- 5-Year CAGR
- -4.3%
- 10-Year CAGR
- -
Sector benchmark
-81.8% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 7.3% year-over-year.
- Ranks #18 out of 212 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2016.
- Lowest working capital per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.42 | -7.3% |
| FY2024 | $23.10 | +0.8% |
| FY2023 | $22.92 | +1.9% |
| FY2022 | $22.50 | -27.6% |
| FY2021 | $31.08 | +16.5% |
| FY2020 | $26.69 | +48.7% |
| FY2019 | $17.94 | +66.1% |
| FY2018 | $10.81 | +83.5% |
| FY2017 | $5.89 | -89.1% |
| FY2016 | $53.94 | +85.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026